Project Number 20111203-LEVEY-2011 Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Year 2011 View Full Project Details for A phase IIa, double-blind, placebo-controlled, biomarker study of atomoxetine in subjects with mild cognitive impairment Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) d. Neurotransmitter Receptors Researcher and Organization Principal Investigator LEVEY, ALLAN I Principal Investigator First Name ALLAN Principal Investigator Last Name LEVEY Awardee Organization EMORY UNIVERSITY Awardee State Georgia Contact PI Country United States Project Detail Funding Opportunity Announcement PACT Program FY Overall Cost $280,000 Funding Organization Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Organization Country United States
